Armel SR - Search Results

1

The use of family history questionnaires: an examination of genetic risk estimates and genetic testing eligibility in the non-responder population.

Armel SR, Hitchman K, Millar K, Zahavich L, Demsky R, Murphy J, Rosen B. Armel SR, et al. J Genet Couns. 2011 Aug;20(4):355-64. doi: 10.1007/s10897-011-9359-8. Epub 2011 Mar 30. J Genet Couns. 2011. PMID: 21448763

2

Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.

Metcalfe KA, Poll A, O'Connor A, Gershman S, Armel S, Finch A, Demsky R, Rosen B, Narod SA. Metcalfe KA, et al. Clin Genet. 2007 Sep;72(3):208-17. doi: 10.1111/j.1399-0004.2007.00859.x. Clin Genet. 2007. PMID: 17718858

3

Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation.

Metcalfe KA, Foulkes WD, Kim-Sing C, Ainsworth P, Rosen B, Armel S, Poll A, Eisen A, Gilchrist D, Chudley A, Ghadirian P, Maugard C, Lemire EG, Sun P, Narod SA. Metcalfe KA, et al. Clin Genet. 2008 May;73(5):474-9. doi: 10.1111/j.1399-0004.2008.00988.x. Epub 2008 Mar 12. Clin Genet. 2008. PMID: 18341607 Review.

4

Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update.

Ginsburg O, Ghadirian P, Lubinski J, Cybulski C, Lynch H, Neuhausen S, Kim-Sing C, Robson M, Domchek S, Isaacs C, Klijn J, Armel S, Foulkes WD, Tung N, Moller P, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Ginsburg O, et al. Breast Cancer Res Treat. 2009 Mar;114(1):127-35. doi: 10.1007/s10549-008-9977-5. Epub 2008 May 16. Breast Cancer Res Treat. 2009. PMID: 18483851 Free PMC article.

5

Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.

Eisen A, Lubinski J, Gronwald J, Moller P, Lynch HT, Klijn J, Kim-Sing C, Neuhausen SL, Gilbert L, Ghadirian P, Manoukian S, Rennert G, Friedman E, Isaacs C, Rosen E, Rosen B, Daly M, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Eisen A, et al. J Natl Cancer Inst. 2008 Oct 1;100(19):1361-7. doi: 10.1093/jnci/djn313. Epub 2008 Sep 23. J Natl Cancer Inst. 2008. PMID: 18812548 Free PMC article.

6

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.

Metcalfe KA, Fan I, McLaughlin J, Risch HA, Rosen B, Murphy J, Bradley L, Armel S, Sun P, Narod SA. Metcalfe KA, et al. Gynecol Oncol. 2009 Jan;112(1):68-72. doi: 10.1016/j.ygyno.2008.10.007. Epub 2008 Nov 20. Gynecol Oncol. 2009. PMID: 19019415 Free PMC article.

7

Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.

Finch A, Metcalfe K, Lui J, Springate C, Demsky R, Armel S, Rosen B, Murphy J, Elit L, Sun P, Narod S. Finch A, et al. Clin Genet. 2009 Mar;75(3):220-4. doi: 10.1111/j.1399-0004.2008.01117.x. Clin Genet. 2009. PMID: 19263514

8

The effectiveness of family history questionnaires in cancer genetic counseling.

Armel SR, McCuaig J, Finch A, Demsky R, Panzarella T, Murphy J, Rosen B. Armel SR, et al. J Genet Couns. 2009 Aug;18(4):366-78. doi: 10.1007/s10897-009-9228-x. Epub 2009 May 21. J Genet Couns. 2009. PMID: 19459037

9

Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers.

Vicus D, Shaw PA, Finch A, Rosen B, Murphy J, Armel S, Sun P, Narod SA. Vicus D, et al. Gynecol Oncol. 2010 Sep;118(3):295-8. doi: 10.1016/j.ygyno.2010.05.012. Gynecol Oncol. 2010. PMID: 20722102

10

BRCA1 and BRCA2 families and the risk of skin cancer.

Ginsburg OM, Kim-Sing C, Foulkes WD, Ghadirian P, Lynch HT, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Ginsburg OM, et al. Fam Cancer. 2010 Dec;9(4):489-93. doi: 10.1007/s10689-010-9377-y. Fam Cancer. 2010. PMID: 20809262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page